Thromboangiitis obliterans (TAO, Buerger's disease) is an inflammatory vascular disease affecting small and medium sized arteries and veins. It is characterized by segmental thrombotic occlusions by highly mononuclear cellular thrombi. Its occurrence and re-occurrence is closely related to tobacco use. Immunohistological examinations and the detections of various autoantibodies led to the new paradigm of an immunopathogenesis of TAO. Clinically it is characterized by distal ischemia syndromes in young people and high amputation rates. This article summarizes the disease characteristics, clinical features, and diagnostic and therapeutic approaches and focuses on new therapeutic options, i.e. stem cell derived therapies, immunoadsorption, and the endothelin-receptor-blocking agent bosentan.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1024/0301-1526/a000371 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment Options for Buerger Disease: A Systematic Review and Meta-Analysis of Outcomes.
J Surg Res
January 2025
Division of Plastic & Reconstructive Surgery, Department of Surgery, University of Florida, Gainesville, Florida. Electronic address:
Introduction: Uncertainties exist regarding the optimal management strategy for patients with thromboangiitis obliterans (TAOs). The aim of this study was to investigate the safety and effectiveness of common interventions used for treating patients with TAO.
Methods: Endovascular treatment, revascularization, sympathectomy, stem cell therapy (SCT), and nonsurgical interventions were selected for inclusion in the study.
Tetrahydrocannabinol vape-associated cannabis arteritis in a patient with minimal tobacco exposure.
J Vasc Surg Cases Innov Tech
February 2025
Division of Vascular Surgery, Department of Surgery, Johns Hopkins Bayview Medical Center, Baltimore, MD.
Thromboangiitis obliterans (TAO) is an inflammatory vasculopathy that often presents in young men with substantial tobacco use. Cannabis arteritis is the cannabis-associated counterpart, but there remains controversy over its classification due to overwhelming concurrent tobacco use. A 31-year-old man developed lifestyle-limiting claudication that coincided with vaping high-potency tetrahydrocannabinol.
View Article and Find Full Text PDFDistinct patient characteristics are associated with clinical presentation and prognosis in thromboangiitis obliterans.
Vasa
January 2025
Department of Cardiology and Angiology, University Hospital Tübingen, Germany.
Thromboangiitis obliterans (TAO) is a rare but threatening disease associated with significant morbidity and mortality. The pathophysiology is poorly understood, the diagnosis is often obscure and causal treatment options are limited. In the current study, we aimed to identify distinct TAO patient clusters that differed in clinical presentation and prognosis.
View Article and Find Full Text PDFThromboangiitis Obliterans (Buerger's Disease).
QJM
November 2024
Department of Rheumatology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-minami-machi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
Elevation and distraction of the Tibial periosteum in the management of chronic ischemic lower limb diseases.
J Orthop Surg (Hong Kong)
October 2024
Department of Orthopaedics, Yueyang Central Hospital, Yueyang, People's Repulic of China.
Objective: This study investigates the effectiveness of tibia periosteum distraction (TPD) applied to the tibial periosteum, an innovative approach grounded in Ilizarov's tension-stress theory, for the treatment of ischemic diabetic foot and vasculitic foot conditions.
Methods: A retrospective analysis was conducted on 33 patients (36 limbs) who underwent TPD between June 2019 and May 2022. The study comprised 21 males (23 limbs) and 12 females (13 limbs), aged 41 to 80 years (mean age: 63.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!